Luis T. Campos
Luis T. Campos publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #1,325,116 of 7,710,434 ranked researchers
- Rank in United States
- #420,684 of 1,627,098
- Works
- 56
- Citations
- 2.4k
- Citations per work
- 42.1
What does Luis T. Campos research?
Luis T. Campos's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3256.5%
- Medicine3256.5%
- Everything else2137.6%
- Life Sciences35.9%
- 1Oncology24% of their works
- 2Pulmonary and Respiratory Medicine12% of their works
- 3Surgery9% of their works
- 4Hematology6% of their works
- 5Molecular Biology6% of their works
- 6Hepatology5% of their works
Research topics
- Cancer Treatment and Pharmacology
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Organ Transplantation Techniques and Outcomes
- Breast Cancer Treatment Studies
- PI3K/AKT/mTOR signaling in cancer
Which keywords describe Luis T. Campos's research?
The keywords of their largest research topics: Chemotherapy-Induced Peripheral Neuropathy, EGFR Mutations, Targeted Therapy, Taxanes, Clinical Practice Guidelines, Molecular Subtypes, Cetuximab and Hepatocellular Carcinoma.
- mTOR
- Gene Expression
- PD-1 and PD-L1
- Liver Cancer
- Ischemia-Reperfusion Injury
- Hepatocellular Carcinoma
- Molecular Subtypes
- Taxanes
- EGFR Mutations
- Chemotherapy-Induced Peripheral Neuropathy
- Targeted Therapy
- Clinical Practice Guidelines
- Cetuximab
- Immune Checkpoint Blockade
- KRAS Mutations
- Liver Transplantation
- Breast Tumours
- Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Chemotherapy-Induced Peripheral Neuropathy101 topic
- EGFR Mutations101 topic
- Targeted Therapy101 topic
- Taxanes101 topic
- Clinical Practice Guidelines92 topics
- Molecular Subtypes92 topics
- Cetuximab51 topic
- Hepatocellular Carcinoma51 topic
- Immune Checkpoint Blockade51 topic
- Ischemia-Reperfusion Injury51 topic
- KRAS Mutations51 topic
- Liver Cancer51 topic
- Liver Transplantation51 topic
- PD-1 and PD-L151 topic
- Breast Tumours41 topic
- Gene Expression41 topic
- Signaling41 topic
- mTOR41 topic
Where does Luis T. Campos work?
Luis T. Campos's main affiliation in the publication record is Hematology Oncology Consultants, United States.
How many publications and citations does Luis T. Campos have?
OpenAlex counts 56 works and 2,359 citations for Luis T. Campos, an h-index of 16, ranking #1,325,116 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luis T. Campos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.